WallStreetZenWallStreetZen

NASDAQ: STOK
Stoke Therapeutics Inc Stock Ownership - Who owns Stoke Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Stoke Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan AllanGENERAL COUNSEL CORP SEC2025-12-081,300$31.60
$41.07kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-12-082,678$32.61
$87.34kSell
Edward M. Md KayeDirector2025-12-083,825$31.44
$120.25kSell
Edward M. Md KayeDirector2025-12-088,274$32.52
$269.07kSell
Edward M. Md KayeDirector2025-12-081,331$33.10
$44.06kSell
Jonathan AllanGENERAL COUNSEL CORP SEC2025-12-055,437$31.08
$169.00kSell
Barry TichoCHIEF MEDICAL OFFICER2025-12-051,989$31.35
$62.35kSell
Barry TichoCHIEF MEDICAL OFFICER2025-12-051,673$31.33
$52.42kSell
Edward M. Md KayeDirector2025-12-056,367$31.33
$199.48kSell
Edward M. Md KayeDirector2025-12-051,681$31.15
$52.36kSell

1 of 7

STOK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when STOK insiders and whales buy or sell their stock.

STOK Shareholders

What type of owners hold Stoke Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Seth Loring Harrison59.44%33,948,426$1.08BInsider
Apple Tree Partners IV LP30.05%17,161,713$547.63MInsider
Blackrock Inc9.13%5,212,554$166.33MInstitution
Trust Skorpios6.84%3,906,181$124.65MInsider
Morgan Stanley6.21%3,546,158$113.16MInstitution
Rtw Investments LP6.21%3,544,248$113.10MInsider
Vanguard Group Inc5.51%3,149,239$100.49MInstitution
State Street Corp4.37%2,498,049$79.71MInstitution
Siren LLC3.93%2,247,347$71.71MInstitution
Assenagon Asset Management Sa2.15%1,227,723$39.18MInstitution

1 of 3

STOK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
STOK30.25%69.75%Net SellingNet Selling
INVA54.14%45.86%Net SellingNet Selling
MBX24.77%75.23%Net Buying
SNDX60.44%10.73%Net SellingNet Selling
RXRX49.09%13.86%Net SellingNet Selling
View Top Biotech Stocks

Stoke Therapeutics Stock Ownership FAQ

Who owns Stoke Therapeutics?

Stoke Therapeutics (NASDAQ: STOK) is owned by 45.36% institutional shareholders, 104.58% Stoke Therapeutics insiders, and 0.00% retail investors. Seth Loring Harrison is the largest individual Stoke Therapeutics shareholder, owning 33.95M shares representing 59.44% of the company. Seth Loring Harrison's Stoke Therapeutics shares are currently valued at $1.06B.

If you're new to stock investing, here's how to buy Stoke Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.